Evoke Pharma, Inc.

2mon ago, source: CNN

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility ...

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

1mon ago, source: Stockhouse

SOLANA BEACH, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with ...

Evoke Pharma, Inc.: Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer

1mon ago, source: Finanznachrichten

SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases ...

Evoke Pharma, Inc. (EVOK)

1mon ago, source: Yahoo Finance

April 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on ...

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

1mon ago, source: Yahoo Finance

SOLANA BEACH, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases ...

Evoke Pharma, Inc. Common Stock (EVOK)

9y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Evoke Pharma Inc EVOK

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Evoke Pharma Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Evoke Pharma Inc (EVOK)

1mon ago, source: Investing

Investing.com - Evoke Pharma (NASDAQ: EVOK) reported first quarter EPS of $-0.5400, $0.01 worse than the analyst estimate of $-0.5300. Revenue for the quarter came in at $796K ...